Qlife Holding AB (publ)

Stockholm Stock Exchange QLIFE.ST

Qlife Holding AB (publ) Gross Profit Margin for the year ending December 31, 2023: -2,586.89%

Qlife Holding AB (publ) Gross Profit Margin is -2,586.89% for the year ending December 31, 2023, a -4,230.25% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.

Qlife Holding AB (publ) Gross Profit Margin for the year ending December 31, 2022 was -59.74%, a -153.13% change year over year.
Qlife Holding AB (publ) Gross Profit Margin for the year ending December 31, 2021 was 112.44%, a -34.61% change year over year.
Qlife Holding AB (publ) Gross Profit Margin for the year ending December 31, 2020 was 171.97%, a 105.00% change year over year.
Qlife Holding AB (publ) Gross Profit Margin for the year ending December 31, 2019 was 83.89%.

Key data

Date	Gross Profit Margin	Operating Income Margin	EBT Margin	Net Income Margin

Stockholm Stock Exchange: QLIFE.ST

Qlife Holding AB (publ)

CEO	Mr. Thomas Warthoe
IPO Date	March 2, 2020
Location	Sweden
Headquarters	Redaregatan 48
Employees	24
Sector	Health Care
Industries Pharmaceuticals Biotechnology Medical Instruments

Description

Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents. The company offers Egoo.Health Platform, an integrated platform with a measuring instrument with disposable capsules and software, where each capsule contains a test for a specific biomarker or virus. Its biomarkers include C-reactive protein home-testing capsule, PHE/Phenylalanine for PKU patients, and Sars-CoV-2/Influenza multiplex for virus/bacteria tests. The company was incorporated in 2019 and is based in Helsingborg, Sweden.

Key trends

Past 5 years